1996
DOI: 10.1016/0304-3835(96)04369-8
|View full text |Cite
|
Sign up to set email alerts
|

The pleiotropic effect of TPA on in vitro invasion/migration of glioma and melanoma cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

1998
1998
2012
2012

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…Divergent responses in different biological systems to phorbol ester-induced translocation and down-regulation have been extensively documented in the literature for the PKC isoforms. For example, although TPA causes PKC␣ and PKC␤I down-regulation in glioma cells, the same treatment of melanoma cells does not lead to changes in the levels of PKC (41). Therefore, the possibility remains that, as with PKC, the differences in RasGRP1 down-regulation in response to phorbol esters may be the result of the different cell types examined.…”
Section: Fig 6 Activation Of Erk In Mouse Keratinocytes Overexpressmentioning
confidence: 82%
“…Divergent responses in different biological systems to phorbol ester-induced translocation and down-regulation have been extensively documented in the literature for the PKC isoforms. For example, although TPA causes PKC␣ and PKC␤I down-regulation in glioma cells, the same treatment of melanoma cells does not lead to changes in the levels of PKC (41). Therefore, the possibility remains that, as with PKC, the differences in RasGRP1 down-regulation in response to phorbol esters may be the result of the different cell types examined.…”
Section: Fig 6 Activation Of Erk In Mouse Keratinocytes Overexpressmentioning
confidence: 82%
“…TPA, an activator of the protein kinase C, is known to be involved in cell proliferation, differentiation, and migration [41]. Prolonged treatment with TPA had been shown to increase migration and invasion in tumor cells [42]. SB, a histone deacetylase inhibitor, is known to inhibit proliferation, induce apoptosis and differentiation in cancer cells [43].…”
Section: Discussionmentioning
confidence: 99%
“…One explanation for the conflict is that individual glioblastomas express unique profiles of PKC isozymes (Couldwell et al, 1990;Pollack et al, 1991;Szaniawska et al, 1996). PKC-a has been implicated in proliferation and in suppression of apoptosis (Shen and Glazer, 1998), whereas PKC-g augments anchorage-independent growth in cell culture (Mishima et al, 1994).…”
Section: Discussionmentioning
confidence: 99%